Entries by Venionaire

Longevity Tech: How Personalized Medicine, Neurofeedback, and Mitochondrial Health Are Redefining Lifespan

Longevity is no longer a niche topic reserved for academic research—it is rapidly becoming one of the most dynamic frontiers in healthcare innovation and venture capital. As discussed in a recent episode of Let’s Talk About Tech, the convergence of personalized medicine, advanced diagnostics, and emerging therapies is reshaping how we think about aging, healthspan, and performance.

Venture Capital Market Turns Its Back on Startups, According to EVSI Report: “I Wouldn’t Want to Be a Founder Right Now”

Venionaire’s European Venture Sentiment Index tracks investment activity and sentiment among top European investors at the end of each quarter and provides an outlook on what the industry expects. In the first quarter of 2026, the European venture capital market experienced a turnaround. “While the investment volume has risen to around $21.3 billion, this amount is being spread across fewer and fewer companies,” explains Berthold Baurek-Karlic, CEO of Venionaire Capital AG. The outlook for the second quarter could hardly be worse.

Small Modular Generators: A New Layer of Energy Infrastructure

For years, Small Modular Reactors (SMRs) have been positioned as the future of nuclear energy. However, SMGs introduce a fundamentally different approach. Instead of relying on a continuous chain reaction, SMGs use accelerator-driven systems to trigger energy release. This removes several of the structural risks associated with nuclear energy and reframes the entire category.

WHERE TO FIND US

VIENNA, OFFICE (HQ)

Babenbergerstraße 9/12,
A-1010 Vienna, Austria (EU)
office@venionaire.com

SAN FRANCISCO, USA

1355 Market St. #488
San Francisco CA 94103
sfo@venionaire.com

NEW YORK CITY, USA

122 East 37th Street
First Floor
New York, NY 10016
nyc@venionaire.com

LONDON, UK

Gable House, 239 Regents Park Road
London N3 3LF
office@venionaire.com

Luxembourg, LUX

28, Boulevard F.W. Raiffeisen
2411 Luxembourg
office@venionaire.com

LOOKING FOR FUNDING?

FOR STARTUPS

Venionaire Capital exclusively invests through the European Super Angels Club, for more information and application please go to the website. We do not accept direct investment proposals via this website.